Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IFT57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KDELR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDF2L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHST12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H4H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK2A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Homologene neighbors
ZNF275 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTRR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GYG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLDIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PALD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLSTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OCIAD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on